Reactive Disruption of the Hippocampal Neurogenic Niche After Induction of Seizures by Injection of Kainic Acid in the Amygdala.

amygdala gliosis hippocampal neurogenesis neural stem cells seizures

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2019
Historique:
received: 20 03 2019
accepted: 29 07 2019
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 5 9 2019
Statut: epublish

Résumé

Adult neurogenesis persists in the adult hippocampus due to the presence of multipotent neural stem cells (NSCs). Hippocampal neurogenesis is involved in a range of cognitive functions and is tightly regulated by neuronal activity. NSCs respond promptly to physiological and pathological stimuli altering their neurogenic and gliogenic potential. In a mouse model of mesial temporal lobe epilepsy (MTLE), seizures triggered by the intrahippocampal injection of the glutamate receptor agonist kainic acid (KA) induce NSCs to convert into reactive NSCs (React-NSCs) which stop producing new neurons and ultimately generate reactive astrocytes thus contributing to the development of hippocampal sclerosis and abolishing neurogenesis. We herein show how seizures triggered by the injection of KA in the amygdala, an alternative model of MTLE which allows parallel experimental manipulation in the dentate gyrus, also trigger the induction of React-NSCs and provoke the disruption of the neurogenic niche resulting in impaired neurogenesis. These results highlight the sensitivity of NSCs to the surrounding neuronal circuit activity and demonstrate that the induction of React-NSCs and the disruption of the neurogenic niche are not due to the direct effect of KA in the hippocampus. These results also suggest that neurogenesis might be lost in the hippocampus of patients with MTLE. Indeed we provide results from human MTLE samples absence of cell proliferation, of neural stem cell-like cells and of neurogenesis.

Identifiants

pubmed: 31482091
doi: 10.3389/fcell.2019.00158
pmc: PMC6710991
doi:

Types de publication

Journal Article

Langues

eng

Pagination

158

Références

Neuroscience. 1999 Mar;89(3):717-29
pubmed: 10199607
J Neurosci. 2001 Sep 15;21(18):7153-60
pubmed: 11549726
Epilepsia. 2002;43 Suppl 5:68-73
pubmed: 12121298
Eur J Neurosci. 2003 Nov;18(10):2769-78
pubmed: 14656326
Neurobiol Dis. 2004 Dec;17(3):473-90
pubmed: 15571983
Ann Neurol. 2005 Aug;58(2):211-23
pubmed: 16049933
Ann Neurol. 2006 Jan;59(1):81-91
pubmed: 16261566
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8233-8
pubmed: 16702546
Exp Neurol. 2007 Feb;203(2):320-32
pubmed: 17049346
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17501-6
pubmed: 17088541
Methods Cell Biol. 2008;85:243-72
pubmed: 18155466
Brain Res. 2008 Jun 5;1213:140-51
pubmed: 18455706
PLoS One. 2008 Apr 09;3(4):e1959
pubmed: 18509506
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11352-7
pubmed: 18682560
Nat Neurosci. 2008 Oct;11(10):1153-61
pubmed: 18758458
PLoS Biol. 2008 Oct 7;6(10):e246
pubmed: 18842068
Acta Neurol Scand Suppl. 2009;(189):8-13
pubmed: 19566491
Science. 2009 Jul 10;325(5937):210-3
pubmed: 19590004
J Neurosci. 2009 Oct 28;29(43):13532-42
pubmed: 19864566
Biochem Biophys Res Commun. 2010 Mar 19;393(4):864-71
pubmed: 20171185
Cell Stem Cell. 2011 May 6;8(5):566-79
pubmed: 21549330
Nature. 2011 Aug 03;476(7361):458-61
pubmed: 21814201
Nature. 2012 Sep 6;489(7414):150-4
pubmed: 22842902
Trends Neurosci. 2013 Mar;36(3):174-84
pubmed: 23298414
Epilepsy Behav. 2013 Jun;27(3):461-9
pubmed: 23611738
Cell. 2013 Jun 6;153(6):1219-1227
pubmed: 23746839
Cell Stem Cell. 2015 May 7;16(5):488-503
pubmed: 25957904
Brain Stimul. 2015 Nov-Dec;8(6):1021-1024
pubmed: 26281755
Nature. 2018 Mar 15;555(7696):377-381
pubmed: 29513649
Cell Stem Cell. 2018 Apr 5;22(4):589-599.e5
pubmed: 29625071
Cereb Cortex. 2018 Jul 1;28(7):2458-2478
pubmed: 29722804
Nat Med. 2019 Apr;25(4):554-560
pubmed: 30911133
Cell Stem Cell. 2019 Jun 6;24(6):974-982.e3
pubmed: 31130513
J Comp Neurol. 1965 Jun;124(3):319-35
pubmed: 5861717
J Neurosci. 1997 May 15;17(10):3727-38
pubmed: 9133393
Neurosci Lett. 1998 May 8;247(1):9-12
pubmed: 9637397
Nat Med. 1998 Nov;4(11):1313-7
pubmed: 9809557
Ann Neurol. 1998 Dec;44(6):923-34
pubmed: 9851437

Auteurs

Teresa Muro-García (T)

The Neural Stem Cell and Neurogenesis Laboratory, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.

Soraya Martín-Suárez (S)

The Neural Stem Cell and Neurogenesis Laboratory, Achucarro Basque Center for Neuroscience, Leioa, Spain.

Nelson Espinosa (N)

Departamento de Psiquiatría, Centro Interdisciplinario de Neurociencia, Pontificia Universidad Católica de Chile, Santiago, Chile.

Roberto Valcárcel-Martín (R)

The Neural Stem Cell and Neurogenesis Laboratory, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.

Ainhoa Marinas (A)

Epilepsy Unit, University Hospital of Cruces, Bilbao, Spain.

Laura Zaldumbide (L)

Epilepsy Unit, University Hospital of Cruces, Bilbao, Spain.

Lara Galbarriatu (L)

Epilepsy Unit, University Hospital of Cruces, Bilbao, Spain.

Amanda Sierra (A)

Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.
Laboratory of Glial Cell Biology, Achucarro Basque Center for Neuroscience, Leioa, Spain.
IKERBASQUE, The Basque Foundation for Science, Bilbao, Spain.

Pablo Fuentealba (P)

Departamento de Psiquiatría, Centro Interdisciplinario de Neurociencia, Pontificia Universidad Católica de Chile, Santiago, Chile.

Juan Manuel Encinas (JM)

The Neural Stem Cell and Neurogenesis Laboratory, Achucarro Basque Center for Neuroscience, Leioa, Spain.
Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.
IKERBASQUE, The Basque Foundation for Science, Bilbao, Spain.

Classifications MeSH